Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for pediatric AIDS.

G Bauer1, D Selander, B Engel

  • 1Division of Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, Departments of Pediatrics and Molecular Microbiology & Immunology, University of Southern California School of Medicine, Los Angeles, California 90027, USA.

Annals of the New York Academy of Sciences
|December 29, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Freezing chicken semen: Influence of base medium osmolality, cryoprotectants, cryoprotectant concentration, and cooling rate on post-thaw sperm survival.

Cryobiology·2022
Same author

Risk factors associated with the welfare of grazing dairy cows in spring-calving, hybrid pasture-based systems.

Preventive veterinary medicine·2022
Same author

Effects of transport age and calf and maternal characteristics on health and performance of veal calves.

Journal of dairy science·2021
Same author

Calf and dam characteristics and calf transport age affect immunoglobulin titers and hematological parameters of veal calves.

Journal of dairy science·2021
Same author

Cow and herd-level risk factors associated with mobility scores in pasture-based dairy cows.

Preventive veterinary medicine·2020
Same author

Effects of pretransport diet, transport duration, and type of vehicle on physiological status of young veal calves.

Journal of dairy science·2020

Gene therapy using retroviral vectors shows promise for treating HIV-1 infection by suppressing viral replication. While safe and feasible in children, further research is needed to improve gene transfer levels for sustained efficacy.

Area of Science:

  • * Molecular Biology
  • * Immunology
  • * Gene Therapy

Background:

  • * Human Immunodeficiency Virus type 1 (HIV-1) infection remains a significant global health challenge.
  • * Gene therapy is being explored as a novel therapeutic strategy to combat HIV-1.
  • * Retroviral vectors offer a potential delivery mechanism for anti-HIV-1 genes.

Purpose of the Study:

  • * To assess the safety and feasibility of gene transfer in pediatric patients with Acquired Immunodeficiency Syndrome (AIDS).
  • * To evaluate the efficacy of retroviral vectors carrying anti-HIV-1 genes in suppressing viral replication.
  • * To identify areas for improvement in gene transfer methods for future HIV-1 gene therapy trials.

Main Methods:

  • * Development of retroviral vectors engineered to express anti-HIV-1 genes (RRE decoy).

Related Experiment Videos

  • * Isolation and transduction of CD34+ hematopoietic stem cells with the retroviral vector.
  • * Clinical trial involving bone marrow harvest, cell re-infusion, and monitoring in pediatric AIDS patients.

    • Main Results:

    • * Gene transfer into pediatric AIDS patients was demonstrated to be safe and feasible.
    • * Significant suppression of HIV-1 replication was observed in laboratory cultures of hematopoietic cells.
    • * Low levels of gene-containing leukocytes were detected in peripheral blood, primarily in the early months post-infusion.

    Conclusions:

    • * Gene therapy is a safe and feasible approach for pediatric AIDS patients.
    • * Current gene transfer methods require enhancement to achieve sustained gene expression and higher efficacy.
    • * Future gene therapy strategies aim to generate HIV-1 resistant T lymphocytes and monocytic cells, potentially complementing antiretroviral therapy.